OR WAIT null SECS
September 06, 2018
The purchase of Novartis’ cystic fibrosis products TOBI Podhaler and TOBI solution is expected to strengthen Mylan’s global respiratory portfolio.
August 27, 2018
The Coalition for Epidemic Preparedness Innovations (CEPI) and vaccine manufacturer IDT Biologika will collaborate to develop and manufacture a vaccine against Middle East Respiratory Syndrome Coronavirus (MERS-CoV).
August 16, 2018
The companies entered a multi-year R&D collaboration to develop mRNA-based flu vaccines.
August 08, 2018
Avalon and Weill will co-develop bio-production and standardization procedures for CAR-T therapy.
August 06, 2018
The companies will collaborate on the discovery, development, and commercialization of cell therapies for cancer.
Boehringer Ingelheim joins Oxford BioMedica, UK Cystic Fibrosis Gene Therapy Consortium, and Imperial Innovations to form a partnership for developing a new gene therapy to treat cystic fibrosis.
August 03, 2018
The companies will collaborate to bring InnoCore Pharmaceuticals’ proprietary SynBiosys biodegradable polymer platform to market.
August 02, 2018
Stem-cell developer TiGenix has been acquired by Takeda Pharmaceutical for approximately EUR 520 million (US$604 million).
Frustrated by slow market adoption, Gottlieb maps out new plan for biosimilar competition.
August 01, 2018
GlaxoSmithKline and 23andMe, a personal genomics and biotechnology company, will partner to research and develop new drugs using human genetics.